Health Canada has authorized the use of the Novavax vaccine in Canada.
The two-dose vaccine showed 90 per cent effectiveness in protecting clinical trial participants aged 18 and above against CxjmtzywOVID-19.
RELATED IMAGESview larger image
A vial of the Phase 3 Novavax coronavirus vaccine is seen ready for use in the trial at St. George’s University hospital in London Wednesday, Oct. 7, 2020. (AP Photo/Alastair Grant)
